Annual EBITDA
$17.91 M
-$4.03 M-18.35%
December 31, 2024
Summary
- As of March 13, 2025, ENFN annual EBITDA is $17.91 million, with the most recent change of -$4.03 million (-18.35%) on December 31, 2024.
- During the last 3 years, ENFN annual EBITDA has risen by +$289.82 million (+106.59%).
- ENFN annual EBITDA is now -18.35% below its all-time high of $21.93 million, reached on December 31, 2023.
Performance
ENFN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$4.83 M
-$1.11 M-18.68%
December 31, 2024
Summary
- As of March 13, 2025, ENFN quarterly EBITDA is $4.83 million, with the most recent change of -$1.11 million (-18.68%) on December 31, 2024.
- Over the past year, ENFN quarterly EBITDA has dropped by -$818.00 thousand (-14.48%).
- ENFN quarterly EBITDA is now -29.24% below its all-time high of $6.83 million, reached on June 30, 2021.
Performance
ENFN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$17.91 M
-$818.00 K-4.37%
December 31, 2024
Summary
- As of March 13, 2025, ENFN TTM EBITDA is $17.91 million, with the most recent change of -$818.00 thousand (-4.37%) on December 31, 2024.
- Over the past year, ENFN TTM EBITDA has dropped by -$4.03 million (-18.35%).
- ENFN TTM EBITDA is now -18.35% below its all-time high of $21.93 million, reached on December 31, 2023.
Performance
ENFN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ENFN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.4% | -14.5% | -18.4% |
| 3 y3 years | +106.6% | -7.3% | -7.4% |
| 5 y5 years | +19.2% | -7.3% | -7.4% |
ENFN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -18.4% | +106.6% | -26.2% | +101.7% | -18.4% | +106.0% |
| 5 y | 5-year | -18.4% | +106.6% | -29.2% | +101.7% | -18.4% | +106.0% |
| alltime | all time | -18.4% | +106.6% | -29.2% | +101.7% | -18.4% | +106.0% |
Enfusion EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $17.91 M(-18.4%) | $4.83 M(-18.7%) | $17.91 M(-4.4%) |
| Sep 2024 | - | $5.94 M(+6.5%) | $18.73 M(+4.1%) |
| Jun 2024 | - | $5.58 M(+257.2%) | $18.00 M(+6.2%) |
| Mar 2024 | - | $1.56 M(-72.4%) | $16.95 M(-22.7%) |
| Dec 2023 | $21.93 M(-490.3%) | $5.65 M(+8.4%) | $21.93 M(+13.4%) |
| Sep 2023 | - | $5.21 M(+15.1%) | $19.35 M(+3.0%) |
| Jun 2023 | - | $4.53 M(-30.8%) | $18.78 M(+57.0%) |
| Mar 2023 | - | $6.55 M(+113.8%) | $11.96 M(-312.8%) |
| Dec 2022 | -$5.62 M | $3.06 M(-34.0%) | -$5.62 M(-98.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $4.64 M(-302.5%) | -$299.89 M(+0.4%) |
| Jun 2022 | - | -$2.29 M(-79.2%) | -$298.61 M(+3.1%) |
| Mar 2022 | - | -$11.03 M(-96.2%) | -$289.50 M(+6.5%) |
| Dec 2021 | -$271.91 M(-3350.6%) | -$291.21 M(-5019.9%) | -$271.91 M(-3476.9%) |
| Sep 2021 | - | $5.92 M(-13.3%) | $8.05 M(-9.7%) |
| Jun 2021 | - | $6.83 M(+4.1%) | $8.92 M(+326.8%) |
| Mar 2021 | - | $6.56 M(-158.3%) | $2.09 M(-146.7%) |
| Dec 2020 | $8.37 M(-44.3%) | -$11.25 M(-265.9%) | -$4.47 M(-165.9%) |
| Sep 2020 | - | $6.78 M | $6.78 M |
| Dec 2019 | $15.02 M | - | - |
FAQ
- What is Enfusion annual EBITDA?
- What is the all time high annual EBITDA for Enfusion?
- What is Enfusion annual EBITDA year-on-year change?
- What is Enfusion quarterly EBITDA?
- What is the all time high quarterly EBITDA for Enfusion?
- What is Enfusion quarterly EBITDA year-on-year change?
- What is Enfusion TTM EBITDA?
- What is the all time high TTM EBITDA for Enfusion?
- What is Enfusion TTM EBITDA year-on-year change?
What is Enfusion annual EBITDA?
The current annual EBITDA of ENFN is $17.91 M
What is the all time high annual EBITDA for Enfusion?
Enfusion all-time high annual EBITDA is $21.93 M
What is Enfusion annual EBITDA year-on-year change?
Over the past year, ENFN annual EBITDA has changed by -$4.03 M (-18.35%)
What is Enfusion quarterly EBITDA?
The current quarterly EBITDA of ENFN is $4.83 M
What is the all time high quarterly EBITDA for Enfusion?
Enfusion all-time high quarterly EBITDA is $6.83 M
What is Enfusion quarterly EBITDA year-on-year change?
Over the past year, ENFN quarterly EBITDA has changed by -$818.00 K (-14.48%)
What is Enfusion TTM EBITDA?
The current TTM EBITDA of ENFN is $17.91 M
What is the all time high TTM EBITDA for Enfusion?
Enfusion all-time high TTM EBITDA is $21.93 M
What is Enfusion TTM EBITDA year-on-year change?
Over the past year, ENFN TTM EBITDA has changed by -$4.03 M (-18.35%)